Document is current

Article History

Received: 17 September 2021

Accepted: 27 February 2022

First Online: 24 March 2022

Declarations

:

: Informed consent was obtained from all subjects involved in the study.

: Not applicable.

: Professor Hay receives/has received sessional fees and lecture fees from the Australian Medical Council, Therapeutic Guidelines publication, and HETI (formerly New South Wales Institute of Psychiatry) and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, and Blackwell Scientific Publications, Biomed Central and PlosMedicine and she has received research grants from the NHMRC and ARC. She is Chair of the National Eating Disorders Collaboration Steering Committee in Australia (2019–) and was a Member of the ICD-11 Working Group for Eating Disorders (2012–2018) and was Chair Clinical Practice Guidelines Project Working Group (Eating Disorders) of RANZCP (2012–2015). She has consulted for and prepared a report under contract for Takeda (formerly Shire) Pharmaceuticals in regards to Binge Eating Disorder (July 2017) and is a consultant to Takeda Pharmaceuticals. All views in this paper are her own. Stephen Touyz has received royalties from Hogrefe and Huber, Mc Graw Hill Education and Routledge for the publication of books/chapters. He is the Chair of the Shire (Australian) BED Advisory Committee and has received travel grants, research grants and honoraria from Shire for commissioned reports. ST is a member of the Editorial Board of this journal. He is a consultant to Weight Watchers. Dr Mitchison is supported by a National Health and Medical Research Council Early Career Fellowship (Grant No. 1158276). PH, ST are Editors in Chief and DM Associate Editor of the Journal of Eating Disorders Editorial Board. All other authors have no conflicts of interest to declare.